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Foreword
 
The development of the Comprehensive STD Prevention Systems (CSPS) program an­
nouncement marked a major milestone in the efforts of CDC to implement the recom­
mendations of the Institute of Medicine report, The Hidden Epidemic, Confronting 
Sexually Transmitted Diseases, 1997.  With the publication of these STD Program 
Operation Guidelines, CDC is providing STD programs with the guidance to further 
develop the essential functions of the CSPS. Each chapter of the guidelines corresponds 
to an essential function of the CSPS announcement. 
With many STDs, such as syphilis, on a downward trend, now is the time to employ 
new strategies and new ways of looking at STD control. Included in these guidelines 
are chapters that cover areas new to many STD programs, such as community and 
individual behavior change, and new initiatives, such as syphilis elimination. Each 
STD program should use these Program Operation Guidelines when deciding where to 
place priorities and resources. It is our hope that these guidelines will be widely distrib­
uted and used by STD programs across the country in the future planning and manage­
ment of their prevention efforts. 
Judith N. Wasserheit 
Director 
Division of STD Prevention 
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Introduction
 
These guidelines for STD prevention program operations are based on the essential functions contained in the Comprehensive STD Preven­
tion Systems (CSPS) program announcement. The 
guidelines are divided into chapters that follow the 
eight major CSPS sections: Leadership and Program 
Management, Evaluation, Training and Professional 
Development, Surveillance and Data Management, 
Partner Services, Medical and Laboratory Services, 
Community and Individual Behavior Change, Out­
break Response, and Areas of Special Emphasis.  Ar­
eas of special emphasis include corrections, adoles­
cents, managed care, STD/HIV interaction, syphilis 
elimination, and other high-risk populations. 
The target audience for these guidelines is public 
health personnel and other persons involved in man­
aging STD prevention programs. The purpose of these 
guidelines is to further STD prevention by providing a 
resource to assist in the design, implementation, and 
evaluation of STD prevention and control programs. 
The guidelines were developed by a workgroup of 
18 members from program operations, research, sur­
veillance and data management, training, and evalua­
tion. Members included CDC headquarters and field 
staff, as well as non-CDC employees in State STD Pro­
grams and university settings. 
For each chapter, subgroups were formed and as­
signed the task of developing a chapter, using evidence-
based information, when available. Each subgroup 
was comprised of members of the workgroup plus 
subject matter experts in a particular field. All sub­
groups used causal pathways to help determine key 
questions for literature searches. Literature searches 
were conducted on key questions for each chapter. 
Many of the searches found little evidence-based in­
formation on particular topics. The chapter contain­
ing the most evidence-based guidance is on partner 
services. In future versions of this guidance, evidence-
based information will be expanded. Recommenda­
tions are included in each chapter.  Because programs 
are unique, diverse, and locally driven, recommenda­
tions are guidelines for operation rather than standards 
or options. 
In developing these guidelines the workgroup fol­
lowed the CDC publication “CDC Guidelines — Im­
proving the Quality”, published in September, 1996. 
The intent in writing the guidelines was to address ap­
propriate issues such as the relevance of the health 
problem, the magnitude of the problem, the nature of 
the intervention, the guideline development methods, 
the strength of the evidence, the cost effectiveness, 
implementation issues, evaluation issues, and recom­
mendations. 
STD prevention programs exist in highly diverse, 
complex, and dynamic social and health service set­
tings. There are significant differences in availability 
of resources and range and extent of services among 
different project areas. These differences include the 
level of various STDs and health conditions in com­
munities, the level of preventive health services avail­
able, and the amount of financial resources available 
to provide STD services. Therefore, these guidelines 
should be adapted to local area needs.  We have given 
broad, general recommendations that can be used by 
all program areas.  However, each must be used in 
conjunction with local area needs and expectations. 
All STD programs should establish priorities, exam­
ine options, calculate resources, evaluate the demo­
graphic distribution of the diseases to be prevented 
and controlled, and adopt appropriate strategies. The 
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success of the program will depend directly upon how 
well program personnel carry out specific day to day 
responsibilities in implementing these strategies to in­
terrupt disease transmission and minimize long term 
adverse health effects of STDs. 
In this document we use a variety of terms familiar 
to STD readers. For purposes of simplification, we 
will use the word patient when referring to either pa­
tients or clients. Because some STD programs are com­
bined with HIV programs and others are separate, we 
will use the term STD prevention program when re­
ferring to either STD programs or combined STD/HIV 
programs. 
These guidelines, based on the CSPS program an­
nouncement, cover many topics new to program op­
erations. Please note, however, that these guidelines 
replace all or parts of the following documents: 
· Guidelines for STD Control Program Operations, 
1985. 
· Quality Assurance Guidelines for Managing the 
Performance of DIS in STD Control, 1985. 
· Guidelines for STD Education, 1985. 
· STD Clinical Practice Guidelines, Part 1, 1991. 
The following websites may be useful: 
· CDC	 www.cdc.gov 
· NCHSTP	 www.cdc.gov/nchstp/od/nchstp.html 
· DSTD	 www.cdc.gov/nchstp/dstd/dstdp.html 
· OSHA	 www.osha.gov 
· Surveillance in a Suitcase	 www.cdc.gov/epo/surveillancein/ 
· Test Categorization Database	 www.phppo.cdc.gov/clia/testcat.asp 
· Sample Purchasing Specifications	 www.gwu.edu/~chsrp/ 
· STD Memoranda of Understanding	 www.gwumc.edu/chpr/mcph/moustd.pdf 
· National Plan to Eliminate Syphilis	 www.cdc.gov/Stopsyphilis/ 
· Network Mapping	 www.heinz.cmu.edu/project/INSNA/soft_inf.html 
· Domestic Violence	 www.ojp.usdoj.gov/vawo/ 
· Prevention Training Centers	 www.stdhivpreventiontraining.org 
· Regional Title X Training Centers	 www.famplan.org 
www.cicatelli.org 
www.jba-cht.com 
· HEDIS	 www.cdc.gov/nchstp/dstd/hedis.htm 
· Put Prevention Into Practice	 www.ahrq.gov/clinic/ppipix.htm 
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At A Glance: Recommendations & 
Appendices 
For ease of reference, we have compiled all Program Operations Guidelines (POG) recommendations and a 
listing of appendices, organized by chapter, in this At-A-Glance section.  Page numbers for each section are 
identified in parentheses for easy cross-referencing to the larger document. It is important that recommenda­
tions be viewed within the context of supporting documentation. For this reason, the reader is encouraged to 
always consult the narrative text and references for each chapter to obtain background and rationale for various 
recommendations. 
The target audience for the POG is public health personnel and other persons involved in managing STD 
prevention programs. 
The purpose of these guidelines is to further STD prevention by providing a resource to assist in the design, 
implementation, and evaluation of comprehensive STD prevention and control programs. Recommendations 
stated in these guidelines are meant as a guide for STD program managers and staff. Many recommendations 
are stated in general terms, indicating particular activities that should be accomplished by all STD prevention 
programs. Intentionally not indicated in the POG is how a particular task should be accomplished. These 
decisions, of course, must be decided by state and local program management in accordance with local area 
needs and resources. 
A camera-ready version of the entire POG document is also available on our website. Anyone wishing to 
duplicate individual chapters, or the entire document, may download a replica version of the hardcopy by going 
to http:/www.cdc.gov/nchstp/dstd/ProgGuidelines.htm 
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Leadership and Program Management 
Recommendations 
STRATEGIC PLANNING (L-1) 
·	 STD program management should develop and 
maintain statements of mission, vision, and values. 
·	 STD program management should develop strate­
gic plans. 
PROGRAM MANAGEMENT: 
OPERATIONAL PLANNING AND 
EVALUATION (L-3) 
·	 The STD program should establish and maintain a 
system for evaluating each component of the inter­
vention program. 
RESOURCE DEVELOPMENT AND 
MANAGEMENT (L-5) 
·	 Management should establish appropriate policies 
and actions that recognize the importance and re­
quirements for training, professional development, 
and career development programs. 
ADVOCACY, MEDIA RELATIONS, & 
LEGISLATION (L-6) 
·	 Each program should have a system to ensure that 
laws affecting STD prevention are routinely re­
viewed and revised, or developed, as necessary. 
·	 Each state should have a complete set of legal au­
thorities (statute or regulation with statutory au­
thority) that contributes to the goals of STD pre­
vention and reflects both sound scientific and 
technological developments. This set of legal au­
thorities should include, but are not limited to, the 
following: 
·	 STD definitions 
·	 Morbidity reporting of defined diseases to include 
reporting of name, address, disease, sex, age, race, 
and source of report, date of report, and date of 
test 
·	 Laboratory reporting of positive tests to include 
date of report, date of test, name of physician, 
patient’s name, age, race, sex, test performed, and 
test results 
·	 Confidentiality of STD records to the maximum 
extent legally possible including exemption from 
subpoena 
·	 Prenatal testing for STDs to include at least one 
serologic test for syphilis. In high morbidity ar­
eas and outbreak situations, serologic tests should 
be performed during the first and third trimester 
of pregnancy and at delivery 
·	 Ophthalmia neonatorum prophylaxis 
·	 Permission for minors to authorize their own STD 
examinations and treatment without parental con­
sent and holding this and related information ab­
solutely confidential 
PARTNERSHIPS AND 
COLLABORATIONS (L-8) 
·	 STD prevention programs should be partners with 
groups such as reproductive health, schools, cor­
rections facilities, and religious organizations. 
·	 STD programs should have a system to assure 
ongoing interaction with all agencies, including 
CBOs, that may affect STD prevention. 
·	 STD programs should establish referral arrange­
ments for STD prevention activities with appro­
priate service providers. 
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Program Evaluation
 
Recommendations
 
INTRODUCTION (E-1) 
·	 Programs should conduct appropriate, regular and 
ongoing evaluation for self assessment and quality 
improvement. 
PLANNING AN EVALUATION (E-2) 
·	 Programs should plan evaluations early in the de­
velopment of interventions. 
·	 Programs should have a plan of evaluation for all 
important program components, including how and 
when each will be evaluated. 
·	 Program evaluations should be designed and con­
ducted with a clear purpose. 
STEPS IN DESIGNING AND 
CONDUCTING AN EVALUATION (E-3) 
·	 Program managers should develop a written descrip­
tion of the program, including the involvement of 
stakeholders. 
·	 Programs are encouraged to develop logic models 
for goals, objectives, activities, and the targeted 
groups. 
·	 Evaluation results should be shared with stakehold­
ers. 
·	 Evaluation results should be used for program im­
provement and further program planning. 
TYPES OF EVALUATION (E-6) 
·	 A formative evaluation should be conducted when 
a new intervention or program is undertaken or 
when a different way of conducting an interven­
tion is developed. 
·	 An evaluability assessment should be conducted 
when planning an evaluation of any portion of an 
existing program. 
·	 At a minimum, programs should calculate the cost 
per service unit for each of its major prevention pro­
grams. 
PRACTICAL CONSIDERATIONS (E-13) 
·	 Programs should include funds for evaluations in 
their budgets. 
·	 Programs should consider utility standards, feasi­
bility standards, propriety standards, and accuracy 
standards when performing evaluations. 
PROGRAM EVALUATION APPENDICES 
E-A LOGIC MODEL (E-15)
 
E-B EXAMPLES OF OBJECTIVES (E-16)
 
E-C TYPES AND USES OF EVALUATION (E-17)
 
E-D EVALUATION GLOSSARY
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Surveillance and Data Management 
Recommendations 
COMPONENTS AND OPERATION OF A 
SURVEILLANCE SYSTEM (GENERAL 
PRINCIPLES) (S-2) 
·	 STD prevention programs should work with state/ 
local health officers, epidemiologists, and depart­
ments/boards of health to determine which STDs 
and which accompanying case data should be man­
dated according to local needs and priorities. 
·	 Health departments should accept all reports of 
laboratory-confirmed gonococcal or chlamydial in­
fection as case reports, in addition to reports from 
clinicians. A report from either should be consid­
ered sufficient for case-reporting purposes. 
·	 Programs should consider untreated disease as mor­
bidity and report as such (when the patient’s symp­
tom, serology, or sex partner history indicate new 
infection). 
·	 National surveillance case definitions should be used 
when analyzing case reports so surveillance reports 
over time and between jurisdictions are interpret­
able. 
·	 State and local STD prevention programs should 
have a written protocol that outlines health depart­
ment procedures for interacting with providers and 
provider responsibilities and procedures for case re­
porting. Depending on how health department ac­
tivities are organized, this protocol may be part of 
a larger protocol that addresses syphilis, HIV, AIDS, 
tuberculosis, and other communicable diseases. 
·	 STD surveillance programs should be able to iden­
tify and monitor those providers reporting signifi­
cant STD morbidity or serving high-risk popula­
tions. 
·	 STD prevention programs can facilitate provider-
based reporting by making available multiple meth­
ods for receiving STD case reports including toll-
free phone numbers, FAX machines, and direct elec­
tronic reporting (e.g., Internet-based systems). 
·	 Programs should approach medical and nursing 
schools, medical societies, and state licensing boards 
to provide information about reporting require­
ments and the diseases that are reportable to newly 
licensed physicians and upon renewal of license. 
·	 Programs should develop opportunities to interact 
with providers in their community.  This interac­
tion could include presentations at hospital in-ser­
vices, presenting at local and state medical confer­
ences, monthly news letters, etc. 
·	 State and local STD prevention programs should 
routinely provide feedback, (e.g., statistical reports 
or newsletters) to providers, emphasizing the im­
portance of the data to public health prevention 
efforts. 
·	 Programs should establish a system to assure that 
local health jurisdictions are aware of laboratories 
newly licensed to perform STD testing services. 
·	 Laboratories performing STD testing should be sur­
veyed at least once yearly to determine the type, 
level, and results (positive or negative) of testing 
performed. 
·	 Programs are encouraged to establish close work­
ing relationships with both public and private labo­
ratories determined to be priority. 
·	 State and local STD prevention programs should 
routinely provide feedback, (e.g., statistical reports 
or newsletters) to laboratories, emphasizing the im­
portance of the data to public health prevention 
efforts. 
·	 STD surveillance programs should have separate 
fields for provider and laboratory reporting infor­
mation. 
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·	 STD prevention programs should encourage labo­
ratories to report data electronically.  STD preven­
tion programs should develop the expertise to im­
port and use these data electronically. 
·	 STD prevention programs should work with labo­
ratories to electronically capture all of the essential 
data variables for case reporting. Revision of lab 
slips may help capture the necessary data from pro­
viders. 
·	 STD prevention programs should adopt and sup­
port the use of the CSTE algorithm described above 
to resolve disease source when there are multiple 
jurisdictions involved. 
·	 If states have laws that require reporting to coun­
ties, the CSTE algorithm should be reviewed by state 
STD prevention programs, county health depart­
ments, and laboratories, and revised if necessary. 
·	 State and local STD prevention programs should 
collaborate with public health programs that are 
conducting laboratory-based surveillance for other 
notifiable conditions to minimize the redundancy 
of efforts, to efficiently utilize the laboratory’s re­
porting resources, and to ensure that core informa­
tion required for case reporting is being consistently 
captured and reported. 
·	 The STD prevention program’s written protocol for 
laboratory-based surveillance should include discus­
sion of prevalence monitoring. Health department 
and laboratory responsibilities and procedures for 
prevalence monitoring should be clearly stated. 
·	 Visits to laboratories should address prevalence-
monitoring. For laboratories where these data have 
not yet been collected or examined, site visits can 
be a starting point for discussions, leading to the 
collection of these data. 
·	 The laboratory registry should indicate those sites 
that are providing data on prevalence, type of tests 
performed, and provider types served. 
·	 STD prevention programs should work with labo­
ratories to determine whether line-listed data on per­
sons testing negative should be submitted or whether 
aggregate data by sex, age group, race or ethnicity, 
provider type, test type, and testing period should 
be submitted electronically. 
·	 STD prevention programs that support jail, juve­
nile detention, correctional STD screening pro­
grams, or other STD screening programs in teen 
clinics or managed care organizations should con­
duct prevalence monitoring among populations 
being screened. 
·	 STD prevention programs should work with pro­
viders participating in prevalence monitoring to en­
sure they provide needed data to the laboratories. 
·	 STD prevention programs should have screening 
protocols with providers who participate in preva­
lence monitoring. 
METHODS OF SURVEILLANCE (S-10) 
·	 STD prevention programs should develop active 
surveillance protocols to be initiated when there is 
a suspected outbreak of disease, when an evalua­
tion of the surveillance system is occurring, or in 
other instances when active surveillance is appro­
priate (e.g., elimination and eradication campaigns). 
SURVEILLANCE SYSTEM ATTRIBUTES 
(S-12) 
·	 STD prevention programs should apply the infor­
mation presented in the Appendix to determine the 
individual strengths of current surveillance activi­
ties and to identify those areas where changes may 
be needed to better monitor disease levels within 
the program area. 
PERSONNEL, TRAINING, AND 
RESOURCES (S-12) 
·	 Each program should designate a coordinator who 
is responsible for surveillance activities. Depending 
upon program size, additional staff may also be nec­
essary. 
·	 State and local STD prevention programs should 
consider establishing formal staff training and ca­
reer development activities in the area of surveil­
lance information systems. 
·	 To develop and maintain a well-trained surveillance 
staff, STD prevention programs should build on 
public health system initiatives that support the core 
public health functions of assessment and assurance 
and work closely with other public health surveil­
lance programs such as HIV and TB. 
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DATA ANALYSIS, INTERPRETATION, 
AND DISSEMINATION (S-13) 
·	 State STD prevention programs should send line-
listed, electronic prevalence data, not just sum­
mary data reports, to those local control programs 
with participating providers in their jurisdictions. 
·	 State and local STD prevention programs should 
consider media other than hard copy for dissemi­
nation of case-reporting and prevalence monitor­
ing information, e.g., Internet distribution via a 
state or local web site. 
·	 STD prevention programs should obtain input 
from partners about types of reports needed and 
disseminate data in a timely fashion. 
·	 Dissemination protocols should be in place, should 
include the providers or laboratories who provided 
the data, and should be periodically evaluated in 
terms of utility and timeliness. 
DATA MANAGEMENT (S-17) 
·	 STD prevention programs should have an efficient, 
up-to-date central registry that includes the fol­
lowing: 1) patient name, 2) address, including zip 
code or census tract, at time of diagnosis, 3) date 
of birth and age, 4) race/ethnic origin, 5) sex, 6) 
diagnosis, 7) date and results of all positive ana­
tomic sites, 8) treatment dates and regimens, 9) 
provider of services, and 10) laboratory, date of 
report by provider and laboratory.  Additional 
data that are important and should be considered 
are pregnancy and HIV status. Other local vari­
ables should be added, as needed. 
·	 All STD prevention programs should have a plan 
for increasing their capacity to develop, maintain, 
and evaluate information systems. 
·	 State and local STD prevention programs should 
develop the information system capacity for elec­
tronic laboratory reporting of all reportable STDs. 
·	 STD information systems should allow for the 
collection, management, and analysis of line-listed 
data on persons infected with all reportable STDs. 
·	 Information systems used for electronic reporting 
of persons testing positive for syphilis, chlamydia 
or gonorrhea should be modified to include data 
on persons testing negative. 
·	 Once electronic laboratory reporting procedures 
and protocols have been developed and implemen­
tation has begun, STD prevention programs should 
evaluate other sources of electronically reported in­
formation to determine their potential contribution 
to STD surveillance activities. This evaluation 
should identify the standards, relationships, and 
protocols that will need to be developed. 
·	 E-mail and Internet access should be readily avail­
able to STD surveillance coordinators and other 
STD prevention program staff. 
·	 All health departments should familiarize the gen­
eral informatics and health informatics community 
to public health concepts and increase their famil­
iarity with public health information systems. 
·	 STD prevention programs should have policies in 
place and implement them to ensure confidential­
ity of data and data security. 
·	 STD prevention programs should work with other 
programs such as TB and HIV/AIDS to standardize 
confidentiality protocols. 
EVALUATION AND QUALITY 
ASSURANCE (S-21) 
·	 STD prevention programs should evaluate STD sur­
veillance systems at least annually. 
·	 STD data quality should be routinely evaluated. 
·	 STD prevention programs should routinely evalu­
ate the effectiveness and sensitivity of their reactor 
grid. 
PROGRAM EVALUATION APPENDICES 
S-A SURVEILLANCE CASE DEFINITIONS (S-23) 
S-B EXAMPLE REACTOR SURVEILLANCE 
FOLLOW-UP GRID (S-27) 
S-C SAMPLE SEROLOGY LABORATORY SITE 
VISIT REPORT (S-30) 
SAMPLE SEROLOGY LABORATORY SITE VISIT 
REPORT WORKSHEET (S-31) 
S-D EXAMPLE: ANNUAL CLINICAL 
LABORATORY SURVEY CALENDAR YEAR — 
(S-32) 
S-E SURVEILLANCE SYSTEM ATTRIBUTES 
(S-36) 
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Training and Professional 
Development Recommendations 
INTRODUCTION (T-1) 
·	 Programs should have in place or should establish 
a system that incorporates the four basic steps of 
the training process identified under the definition 
for training. 
·	 Programs should develop goals and objectives for 
appropriate training for both staff and external part­
ners. 
·	 Programs should utilize information collected from 
evaluation to update and improve the entire train­
ing process. 
·	 Programs should establish a policy ensuring that 
training, professional development, and career de­
velopment are part of their program. 
·	 Program managers should designate individuals 
with management responsibility for training and 
staff development functions. 
TRAINING PROCESS (T-3) 
·	 STD prevention programs should have a system­
atic and regular method of assessing training needs 
and skills development of staff. 
·	 STD prevention programs should consult with PTCs 
for conducting external partners training needs. 
·	 Programs should perform a needs assessment within 
their STD prevention workforce (both staff and ex­
ternal partners). 
·	 Programs should be aware of areas of training and 
orientation needed for all staff members. 
·	 Programs should evaluate training activities and 
effects on performance. 
·	 Programs should conduct post-training monitoring 
and reinforcement. 
PROFESSIONAL/CAREER 
DEVELOPMENT PROCESS (T-10) 
·	 Programs should consider the mentoring process as 
an effective method for career development. 
TRAINING AND PROFESSIONAL 
DEVELOPMENT APPENDICES 
T-A JOB TITLES IN PUBLIC HEALTH (T-14) 
T-B GENERAL EXAMPLES OF COMPETENCIES 
RELATED TO IDENTIFIED ESSENTIAL 
PUBLIC HEALTH SERVICES (T-15) 
T-C AREAS OF TRAINING IN STD 
PREVENTION (T-18) 
T-D NATIONAL STD/HIV PREVENTION 
TRAINING CENTERS: PART I — CLINICAL 
SERVICES (T-23) 
NATIONAL STD/HIV PREVENTION TRAINING 
CENTERS: PART II — BEHAVIORAL 
INTERVENTIONS (T-24) 
NATIONAL STD/HIV PREVENTION TRAINING 
CENTERS: PART III — PARTNER 
SERVICES (T-24) 
REGIONAL TITLE X TRAINING CENTERS 
(T-25) 
AIDS EDUCATION & TRAINING CENTERS 
(AETCs) (T-26) 
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Medical and Laboratory Services 
Recommendations 
ACCESSIBILITY (ML-1) 
·	 The clinic facility must be physically accessible in 
accordance with the Americans with Disabilities 
Act. 
·	 Clinics should be located so that they are readily 
accessible through public and private transporta­
tion from residential areas. 
·	 The general public should be able to easily deter­
mine how to obtain specialized STD services. 
·	 Clinic hours and staffing should be sufficient to 
accommodate patients, with minimal patients 
turned away. 
·	 A system to periodically assess clinic user (or pa­
tient) satisfaction with services should be in place. 
·	 No patient should be denied care for lack of money. 
Medical services should be at no charge, minimal, 
or based on a sliding scale. 
·	 Fees should not be assessed for examining persons 
referred by a disease intervention specialist. 
RANGE OF SERVICES (ML-2) 
·	 At a minimum, clinics should have the capability 
to accurately diagnose and treat bacterial STDs. 
·	 Clinics should have the capacity to distribute medi­
cations for diseases diagnosed in the clinic. At a 
minimum, medications must be available for locally 
prevalent STDs, with prescriptions available for 
diagnosed diseases not prevalent in the community. 
·	 Clinics should provide condoms and counseling on 
primary prevention to all patients. 
·	 Clinics providing Pap smears should have specific 
protocols for follow-up of abnormal results that in­
clude guidelines for colposcopy referral. 
·	 Clinics providing pregnancy tests should have spe­
cific protocols for follow-up and referral of posi­
tive tests. 
·	 Clinics should collaborate with immunization pro­
grams and viral hepatitis programs to provide hepa­
titis B vaccinations to those at risk. 
·	 Clinics should provide the basic range of HIV re­
lated services specified in state and federal statutes 
and, for patient convenience, should offer as many 
as possible on site (e.g., counseling and testing, part­
ner services). 
·	 Confidential counseling and testing for HIV should 
be offered at the time of the STD visit so that pa­
tients do not have to visit separate clinics or make 
return visits. 
·	 Confidential counseling and testing for STDs, in­
cluding HIV, should not be denied because a pa­
tient refuses other STD services. 
·	 Anonymous HIV testing should be available on site 
for patients requesting the service or at community 
sites convenient to patients. 
·	 Written policy and procedures should be in place 
for the referral of patients for HIV early interven­
tion services (e.g., continuing medical evaluation, 
tuberculosis and immune system testing, treatment, 
and support group counseling). 
·	 When not offered on site, the mechanisms for re­
ferral should be established for relevant health ser­
vices (e.g., family planning, prenatal, adult immu­
nizations, drug counseling). 
CLINIC ENVIRONMENT (ML-3) 
Facility 
·	 The building in which a STD clinic is located should 
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have signs making it easy to locate. Signs at the 
building entrance should be easy to read and should 
clearly list STD among the services. 
·	 Waiting areas should contain accessible patient edu­
cation (i.e., handouts, posters, pamphlets, or au­
diovisuals) that emphasize risk reduction behav­
iors for the prevention of STDs, HIV, and viral 
hepatitis. 
·	 Examination rooms should be clean and private and 
should have adequate equipment and supplies for 
physical examinations and specimen collection for 
both male and female patients. 
·	 The number of examination rooms should be ad­
equate to accommodate the number of clinicians 
(at least one room per clinician) and to serve pa­
tients promptly during the normal working day. 
Patient Considerations 
·	 Patient confidentiality must be maintained. Confi­
dentiality should be promoted by using a system 
other than names when calling patients from wait­
ing areas. 
·	 Clinic personnel should be courteous and respect­
ful of patients. 
·	 Patients should be told what to expect during the 
clinic visit, including being told STDs for which they 
are being tested and the common ones for which 
they are not being tested. 
·	 All clinic staff should develop and maintain 
cross-cultural awareness and display cultural sen­
sitivity. 
·	 An adequate portion of the clinic staff should have 
bilingual fluency that facilitates services to those 
patients who do not speak English. 
·	 Clinics should assess the need for physical security 
during clinic sessions and have security protocols 
in place. 
REGISTRATION PROCESS (ML-3) 
Confidentiality 
·	 Registration information should be obtained in a 
confidential manner. 
·	 Acoustical barriers separating clerks from waiting 
areas in addition to methods of self registration 
should be considered when distance does not pre­
vent persons from overhearing those who are regis­
tering. 
·	 Information collected at the registration desk should 
be relevant: locating and demographic data, type 
of visit (referral, appointment, or walk-in); clerks 
should avoid discussing the medical reason for the 
visit including any symptoms or medical history. 
·	 Patient address should be verified at every visit in 
the event that follow up is needed. 
Procedure 
·	 Telephone reports of test results must follow clinic 
procedures to ensure confidentiality. 
·	 Clinics should have systems in place to assess and 
modify patient visits to assure minimal waiting. 
·	 The “expected-in” file should be checked for every 
person at every visit as part of the registration pro­
cess. 
·	 Priority patients should be given preferential ser­
vice. 
CLINIC FLOW (ML-4) 
Appointment and Walk-in Systems 
·	 The responsibilities of the clinician will play a role 
in determining the number needed in a clinic. 
·	 Walk-in patients with genital ulcers, discharges, and 
women with abdominal pain or who are pregnant 
should be examined that day. 
·	 Patients referred by DIS should be seen on a prior­
ity basis on the same day. 
·	 Walk-in patients who are not examined within the 
day should be given a list of STD medical resources 
and eligibility requirements (e.g., urgent care clin­
ics, family planning clinics, private physicians) and 
encouraged to call for a next-session appointment. 
Clinic Flow 
·	 Clinic flow should be designed so that the next avail­
able clinician sees the next patient registered. An 
exception may be made where local medical prac­
tice standards or legislation stipulates gender re­
quirements. Patients who request a clinician of a 
specific sex should be accommodated whenever 
possible. 
·	 Patient stops should be kept to a minimum (ideally, 
not more than three—registration, clinical care, and 
an STD/HIV interviewing/counseling session, if 
needed). 
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·	 Patient flow analysis should be conducted periodi­
cally to provide a systematic understanding of where 
bottlenecks in clinic flow occur. 
MEDICAL RECORDS (ML-5) 
·	 Medical records should contain sufficient demo­
graphic information to contact the patient and suf­
ficient clinical evaluation information to readily in­
terpret the examining clinician’s assessment and 
clinical findings. 
·	 All procedures concerning content and filing of 
medical records should be in accordance with state 
and local laws and statutes. 
·	 STD programs should follow written procedures for 
the management of medical records that includes 
forms management, organization of the medical 
record, records security, and adherence to statutes 
for record retention. 
·	 An individual should be assigned the responsibility 
of managing the release of records due to subpoena, 
court order, etc.  This person should track all mat­
ters relating to request to view medical records. 
CLINIC MANAGEMENT STRUCTURE 
(ML-6) 
·	 The clinic manager should have adequate special­
ized training in STD, clinic and personnel man­
agement, and public health. 
·	 The medical director should have specialized train­
ing in STD, be available for consultation during 
clinic hours and ensure the overall quality of clini­
cal services. 
CLINIC MANUALS (ML-7) 
Personnel Policies 
·	 An STD clinic manual should contain the goals and 
the objectives of the clinic, including fully integrated 
STD/HIV services. 
·	 Job descriptions and performance standards should 
be provided for all staff members. These descrip­
tions and standards should include: 
1. qualifications and training requirements for 
each job; 
2. the role each job plays in the operation of the 
clinic; 
3. a description of the essential tasks required for 
each job; 
4. the mechanism for performance evaluation; 
and, 
5. attitudes expected to be conveyed to clinic pa­
tients. 
·	 Policies regarding employee health (e.g., injury sur­
veillance, HIV exposure, tuberculosis screening, and 
hepatitis B vaccination) should be consistent with 
state and local employee health regulations and 
should be clearly written and enforced. 
·	 Procedures for formal quality assurance should be 
provided. 
·	 Local policies and procedures included in the 
manual (frequency of staff meetings, fire drill in­
structions, sick leave, and vacation) should be cur­
rent. 
Medical Protocols 
·	 Clinic protocols or standard medical instructions 
for specific patient management should include: 
1. patient evaluation; 
2. management of STDs (See CDC STD Treatment 
Guidelines); 
3. medical consultation and referral; 
4. follow-up after therapy; 
5. counseling/education; 
6. and management of sex partners. 
· Protocols should include current recommended 
treatments for STDs. 
·	 Emergency medical protocols should be current. 
·	 Protocols for the safe handling of blood and body 
fluids (standard precautions) should be current and 
practical for most clinic situations. 
·	 Current and signed standing orders for non-physi­
cian clinicians should be included if required or not 
prohibited by state laws and regulations (medical 
practice acts). 
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 CLINICIAN ROLES AND 
PERFORMANCE STANDARDS (ML-8) 
·	 Nurses, nurse practitioners, and physician assistants 
should work in full compliance with established 
clinic protocols as clinicians responsible for the en­
tire clinical care process, including history taking, 
physical examination, laboratory specimen collec­
tion, diagnosis, treatment, plan for follow-up, and 
counseling/education. 
·	 Non-physician clinicians should have adequate phy­
sician backup and specific standing orders. 
·	 All clinicians should have a specific STD training 
course and AIDS update course. 
STANDARD PRECAUTIONS (ML-8) 
·	 Standard Precautions should be applied to (1) blood; 
(2) all body fluids, secretions, and excretions, ex­
cept sweat, regardless of whether or not they con­
tain visible blood; (3) broken skin; and, (4) mucous 
membranes. Standard Precautions are designed to 
reduce the risk of transmission of microorganisms 
from both recognized and unrecognized sources of 
infection in health care settings. 
·	 Protective barriers should be appropriate and avail­
able for the type of exposure anticipated and may 
include latex or vinyl examination gloves, gowns, 
masks, and protective eye wear. 
·	 Needles and syringes should not be recapped or 
removed from disposable syringes. 
·	 Disposable syringes and other sharp items should 
be placed in puncture-resistant containers located 
in the immediate vicinity where venipuncture pro­
cedures take place. 
·	 Gloves should be worn during venipuncture to re­
duce the incidence of blood contamination, recog­
nizing that they cannot prevent needle-stick inju­
ries. 
·	 Clinicians and phlebotomists should change gloves 
between patients. 
· Gloves should not be worn outside the examina­
tion room or the laboratory. 
·	 Skin on hands or other parts of the body should be 
immediately and thoroughly washed if contami­
nated with blood or other body fluids. Hands 
should always be washed before and after the ex­
amination and before leaving the examination 
room. 
·	 Infectious waste should be incinerated or autoclaved 
before disposal in a sanitary landfill. 
·	 A surveillance system should be established for in­
juries such as needle-sticks, percutaneous injuries, 
and mucous membrane contamination; protocols 
should specify collection of confidential informa­
tion about the worker and about the source indi­
vidual (if applicable and possible), and about the 
cause and type of injury, medical treatment, coun­
seling, and follow-up. 
EMERGENCY PROCEDURES (ML-10) 
·	 One copy of an emergency protocol should be kept 
in the clinic manual and one copy with the emer­
gency supplies. 
·	 Emergency equipment, supplies, and medications 
should be updated frequently according to an es­
tablished schedule to ensure that they are not de­
pleted or expired. Emergency supplies should be 
sealed when not in use. 
·	 All clinical staff members should be trained in car­
diopulmonary resuscitation and should be able to 
respond appropriately in an emergency. 
·	 Staff members should be trained in specific safety 
procedures for managing potentially violent or abu­
sive persons in the clinic. 
·	 Mock emergency drills should be held at least twice 
yearly to ensure that all staff members recognize 
emergencies, know their roles and responsibilities, 
know the location and contents of emergency sup­
plies, can use all equipment properly, and follow 
established protocols. 
·	 STD prevention programs should develop and 
implement policies and procedures to manage oc­
cupational exposures of health care workers. 
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STAT LABORATORY MANAGEMENT of urine pregnancy tests, which are classified as 
STRUCTURE (ML-10) waived under CLIA: 
1. Gram stain to detect intracellular gram-nega-
Laboratory Direction tive diplococci and presence of white blood cells 
·	 The laboratory director should be trained in ap­
propriate laboratory techniques and safety proce­
dures associated with handling infectious agents. 
·	 The director should have experience in public health 
and an understanding of the needs of clinicians and 
DIS staff. 
·	 Optimal qualifications of the laboratory director 
include a doctoral degree in medicine or laboratory 
science (see Appendix ML-A). 
·	 The director should ensure that the quality assur­
ance committee’s recommendations for laboratory 
testing are implemented. 
·	 The laboratory director may be on site or at the 
state or local health department for laboratories that 
have the exemption for limited public health test­
ing. 
·	 Staff members should be familiar with work plans 
and should receive periodic performance evalua­
tions. 
·	 Only personnel who have been advised of potential 
hazards and who meet specific requirements should 
be allowed to enter the laboratory. 
·	 The director should ensure adequate staffing to 
manage the volume of rapid testing during peak test­
ing hours, lunch, and employee vacations. 
·	 Accurate and updated test procedures and biosafety 
manuals should be available to all laboratory em­
ployees. 
·	 Policies should be established to ensure the confi­
dential storage of laboratory requisitions or log 
books containing patients’ test results. Confidenti­
ality statutes in each jurisdiction define the records 
that are protected from subpoena and may specify 
the time frame for retention and the method for 
destruction. 
Laboratory Services 
·	 Each clinic that provides STD services should have 
an on-site stat laboratory or capacity to perform 
stat tests. The laboratory must have a current CLIA 
certificate and be in compliance with CLIA-88 (see 
Appendix ML-A). 
·	 At a minimum, stat laboratories should perform the 
following tests, all of which are classified as of mod­
erate complexity under CLIA, with the exception 
to detect cervicitis or urethritis 
2. nontreponemal antibody card tests for syphilis 
such as RPR, TRUST, RST 
3. darkfield examination for Treponema pallidum 
4. saline wet mount for Trichomonas vaginalis and 
detection of clue cells of bacterial vaginosis 
5. KOH wet mount for the identification of yeast 
and for amine odor (Whiff) test 
6. Urine pregnancy tests 
·	 Point-of-care tests should only be used to provide 
immediate results and treatment to patients. If test­
ing does not occur immediately, tests with greater 
sensitivity and specificity should be used. 
·	 The stat laboratory should contain an appropriate 
number of brightfield and darkfield microscopes and 
adequate equipment, supplies, and reagents to pro­
cess patient specimens rapidly. 
·	 A sufficient number of staff should be trained in 
darkfield microscopy to provide coverage during 
all clinic hours where rapid syphilis diagnosis is de­
sirable. 
·	 The stat laboratory should send the following rou­
tine tests to the state health laboratory or other non-
stat laboratory: 
1. presumptive and confirmatory identification 
and antimicrobial sensitivity tests for N. 
gonorrhoeae; [presumptive-moderate complex­
ity; confirmatory and sensitivity tests-high com­
plexity-CLIA] 
2. chlamydia diagnostic tests (most high complex­
ity - CLIA) nontreponemal antibody tests for 
syphilis (VDRL - high complexity, RPR and 
other similar card tests - moderate complexity 
- CLIA ) 
4. fluorescent treponemal antibody absorption 
(FTA-ABS) or other treponemal tests for syphi­
lis [high complexity-CLIA]; and 
5. HIV antibody tests [moderate complexity-
CLIA, many others, high complexity-CLIA] 
· Additional stat testing may include; 
1. 	Tzanck stain for herpes [moderate-CLIA] 
2. 	spun urine for Gram stain and white cell count 
[moderate-CLIA] 
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 ·	 STD clinics should use routine and reference labo­
ratory services which further facilitate the diagno­
sis of STDs. 
LABORATORIAN ROLES AND 
PERFORMANCE STANDARDS (ML-12) 
·	 Job qualifications for laboratorians include (at a 
minimum) high school graduation and training re­
ceived at a medical or technical school; certifica­
tion as a laboratory technician or technologist, pro­
fessional registration as a microbiologist, or a degree 
in biological science; and, courses in basic stat labo­
ratory methods for STD testing (brightfield and 
darkfield microscopy, gonorrhea culturing, rapid 
chlamydia tests, and syphilis serology) at one of the 
STD Prevention/Training Centers, or similar train­
ing. 
·	 All laboratory workers should routinely participate 
in proficiency testing. 
·	 A laboratory worker should possess a professional 
attitude and sensitivity about confidentiality; this 
includes not discussing laboratory results within pa­
tients’ hearing. 
·	 A laboratory worker should adhere strictly to uni­
versal precautions, safety procedures, and quality 
control procedures. 
LABORATORY BIOSAFETY LEVEL 
CRITERIA (ML-13) 
Microbiological Procedures 
·	 Access to the laboratory should be limited to ap­
propriate personnel and should be restricted when 
work with infectious agents is in progress. 
·	 Work surfaces should be decontaminated daily, as 
well as immediately after a spill. 
·	 All infectious waste should be decontaminated be­
fore disposal. 
·	 Mouth pipetting is prohibited; mechanical pipetting 
devices are used. 
·	 Eating, drinking, smoking, handling contact lenses, 
and applying cosmetics are not permitted in the 
work areas. Contact lens wearers in laboratories 
should also wear goggles or a face shield. Food is 
stored in cabinets or refrigerators designated for that 
purpose only, outside the work area. 
·	 Thorough hand washing should be performed af­
ter handling infectious materials and before leav­
ing the laboratory. 
·	 Procedures to minimize the creation of splashes or 
aerosols should be followed. 
·	 An insect and rodent control program should be in 
effect. 
·	 Universal biohazard symbols should be posted on 
the laboratory door. 
·	 Laboratory personnel should receive appropriate 
immunizations or screening for the agent handled 
or potentially present in the laboratory (e.g., hepa­
titis B vaccine or TB skin testing).Baseline serum 
samples for laboratory and other at-risk personnel 
should be collected and stored, when appropriate, 
considering the agent(s) handled. Additional se­
rum specimens may be collected periodically. 
·	 A biosafety manual should be prepared or adopted. 
Personnel should be advised of special hazards and 
should be required to read and follow instructions 
on practices and procedures. 
·	 Contaminated sharp items, including needles and 
syringes, should be promptly placed in puncture-
proof containers for decontamination. 
·	 Laboratory personnel should receive appropriate 
training on the potential hazards associated with 
the work involved, the necessary precautions to 
prevent exposures, and exposure evaluation pro­
cedures. Personnel should receive periodic updates, 
or as necessary. 
·	 Cultures, tissues, or specimens of body fluids should 
be placed in a container that prevents leakage dur­
ing collection, handling, processing, storage, trans­
port, or shipping. 
·	 Laboratory equipment and work surfaces should 
be decontaminated with an appropriate disinfec­
tant on a routine basis after work with infectious 
materials is finished, and especially after spills. 
·	 Spills and accidents which result in overt exposures 
to infectious materials should be reported to the 
laboratory director immediately. 
Safety Equipment (Primary Barriers) 
·	 Biological safety cabinets, or other appropriate pro­
tective equipment should be used when procedures 
with a potential for creating infectious aerosols or 
splash are conducted, or high concentrations or 
large volumes of infectious agents are used. 
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·	 Face protection (goggles, mask, face shield or other 
splatter guards) should be used for anticipated 
splashes or sprays of infectious materials. 
·	 Protective laboratory coats, gowns, smocks, or uni­
forms designated for lab use should be removed and 
left in the laboratory before leaving for non-labo­
ratory areas. 
·	 Examination gloves should be worn when handling 
infectious materials, contaminated surfaces or 
equipment. Gloves should be disposed of when con­
taminated, or when work with infectious materials 
is completed. Disposable gloves should not be 
washed or reused. 
Laboratory Facilities (Secondary Barriers) 
·	 Each laboratory should contain a sink for washing 
hands. 
·	 The laboratory should be designed for easy clean­
ing. 
·	 Bench tops should be impervious to water and re­
sistant to acids, alkalis, organic solvents, and mod­
erate heat. 
·	 Furniture in the laboratory should be sturdy, with 
spaces between benches, cabinets, and equipment 
accessible for cleaning. 
·	 If the laboratory has windows that open, they 
should be fitted with fly screens. 
·	 A method for decontamination of infectious or regu­
lated laboratory wastes should be available (e.g., 
autoclave, chemical disinfection, incinerator, or 
other approved decontamination system). 
·	 An eyewash facility should be readily available. 
LABORATORY PRACTICE AND 
TECHNIQUES (ML-14) 
Microbiological Practices 
·	 All procedures should be consistent with recognized 
standard and specialized microbiologic practices. 
·	 Biological safety cabinets, previously termed 
“hood,” (Class I or II) or other physical contain­
ment devices should be used during procedures in 
which infectious aerosols may be created. 
·	 Any activity with the potential for creating aero­
sols (e.g., centrifugation of blood) should be per­
formed in low-traffic areas in the laboratory. 
·	 All testing should be performed under quality as­
surance guidelines specific for each test (e.g., con­
trol specimens, temperature, time). 
·	 Safety equipment should include items for personal 
protection such as gloves, coats, face shields, and 
safety glasses. 
·	 Cultures, tissues, or specimens of body fluids should 
be placed in a container that prevents leakage dur­
ing collection, handling, processing, storage, trans­
port, or shipping. Laboratory specimens should be 
placed in durable trays or containers for safe trans­
port, even for short distances. 
Procedures Manual 
·	 The manual should include step-by-step descriptions 
of all methods; modifications of procedures should 
be initialed by the laboratory director. 
·	 The manual should include criteria for laboratory 
specimen acceptability. 
·	 Daily quality control records pertaining to test con­
trols and to equipment, temperature, and speed of 
rotation should be noted in the manual. 
·	 Procedures for quality control checks on new lots 
of reagents, whether purchased or prepared, should 
be noted in a special section. 
·	 Instructions for routine tests and special studies 
should be documented in the manual. 
Biosafety Manual 
·	 All new employees should read and understand the 
biosafety manual before working in the laboratory. 
(See section, Standard Precautions, for OSHA man­
dated training required for all employees who may 
have contact with blood or other body fluids.) 
·	 The manual should include information on stan­
dard and special microbiologic practices appropri­
ate to laboratory Biosafety Level 2. 
·	 The biosafety manual should be regularly updated. 
·	 Laboratory procedures should be reviewed for com­
pliance with established safety practices by a safety 
proctor appointed by the laboratory director. 
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PROVIDING STAT LABORATORY DISEASE INTERVENTION SPECIALIST 
SERVICES IN COMPLIANCE WITH CLIA SERVICES IN MEDICAL FACILITIES 
(ML-15) (ML-17) 
·	 The exemption to the certification requirement for · Consistent prevention messages to patients should 
each location available for limited public health test- be facilitated through regular communication be­
ing (LPHT) should be pursued, if feasible. The state tween clinic providers and DIS. 
public health laboratories may be the only facilities · Clinic procedures should promote a smooth and 
with the mandate, expertise, and infrastructure to confidential exchange of relevant disease interven­
facilitate laboratory partnerships between large tion information between clinical staff and DIS. 
numbers of locally administered clinic laboratories. · DIS should be on site or on call to provide disease 
intervention services during clinic hours. Where 
resources are lacking for specialized disease inter-
VENIPUNCTURE (ML-16) vention staff, or work is reassigned based on dis­
ease priorities, clinicians and counselors can per­
·	 A continuing Quality Assurance program should form intervention services. 
be in place to monitor the venipuncture performance · DIS should have a thorough understanding of STD 
of STD staff. clinical care and STD diagnostic test results. 
·	 The DIS supervisor should closely monitor DIS un- · Clinic protocols should specify which patients are 
til assured that their venipuncture performance is to receive STD and HIV intervention services from 
satisfactory. DIS. 
·	 Periodic monitoring should continue after the ini- · DIS should be provided with an adequate number 
tial observation period. See Appendix ML-F for an of private rooms to ensure that confidential STD 
example of a venipuncture evaluation tool. interviews and HIV prevention counseling sessions 
·	 When labeling and transporting specimens, the DIS can be conducted without interruption. 
should: · All personnel should be evaluated for STD inter­
·	 Print the patient’s name and date of birth (if known) vention and HIV test counseling skills to assure con-
or place a pre-printed label on the specimen tube sistency of messages. 
after the blood has been collected. Include the date 
the specimen was drawn. To prevent the incorrect 
labeling of blood specimens do not pre-label blood QUALITY ASSURANCE PROCEDURES 
collection tubes. (ML-18) 
·	 Maintain blood specimens in an upright position 
with the stopper at the top, either by placing in a · A quality assurance committee should meet regu­
specimen rack or in a cardboard container.  Pack larly and follow an approved protocol to conduct 
the containers tightly so the specimens will be se- audits, analyze findings, and deliver recommenda­
cure in transit. tions. 
·	 Blood specimens should be delivered to the labora- · Medical records should be audited regularly 
tory for processing at the earliest practical time. (checked against clinic protocols) to determine the 
Avoid leaving for extended periods in a car or simi- appropriateness of diagnoses and treatment and the 
lar place where temperatures may become exces- completeness of documentation. 
sively high or low.  Also, make sure specimens re- · The quality of stat laboratory procedures should 
main in your care and that they are not handled by be monitored regularly. 
unauthorized persons. · Staff interactions with patients should be observed 
·	 When blood specimens cannot be delivered to the regularly. 
laboratory on the day of collection, make sure they · Semiannual safety audits should be performed to 
are stored upright in a refrigerator.  Do not freeze, determine the appropriate use of electrical equip-
as hemolysis may occur, ruining the specimen. ment, storage of chemicals, emergency procedures, 
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and first-aid stations. 
·	 A mechanism should be established for receiving, 
reviewing, and responding to complaints of patients. 
·	 Representatives of the finance office and data pro­
cessing unit should also be included on the quality 
assurance committee so that they can gain and main­
tain an understanding of clinic operational needs. 
REPORTING (ML-18) 
Disease Morbidity 
·	 Clinics should promptly submit morbidity reports 
following the diagnosis of a case in the format de­
termined by the state or local prevention program. 
·	 Morbidity reports should be complete, legible, and 
checked for accuracy before submission. 
·	 The quality assurance of morbidity reports should 
involve periodic comparison with medical records. 
·	 Computerized medical record systems should be 
linked to electronic morbidity reporting to expe­
dite rapid data collection. 
·	 Clinic reporting systems should have the necessary 
safeguards to ensure the proper and nonduplicative 
reporting of laboratory results and diagnostic de­
terminations. 
Sexual Assault and Abuse 
·	 All clinic staff should be familiar with provisions 
of the state child abuse and neglect statute and their 
obligations under it. 
·	 Clinic staff members should be familiar with appli­
cable STD and HIV confidentiality statutes and 
should be sensitive to any limitations on the report­
ing of supplementary information about suspected 
abuse cases. 
·	 The clinic manual should specify the management 
of patients of alleged abuse, listing the required ex­
amination and proper handling of laboratory speci­
mens for evidence, and reporting procedures. 
·	 Testing of abused or assaulted patients should be 
performed using the most specific tests available. 
·	 Clinics should set up a mechanism for referrals to 
perform additional confirmatory testing necessary 
to make a definite diagnosis. 
·	 Clinics should have a patient advocate who main­
tains links with victim’s assistance programs. 
Domestic Violence 
·	 All clinic staff members should be familiar with 
domestic violence statutes. 
·	 STD programs should incorporate domestic violence 
issues into their staff training. 
MEDICAL AND LABORATORY 
SERVICES APPENDICES 
ML-A CLIA (ML-22) 
ML-B COMMONLY USED STAT TESTS: SALINE 
AND 10% KOH WET MOUNTS, VAGINAL PH 
(ML-26) 
COMMONLY USED STAT TESTS: GRAM STAIN 
FOR MICROORGANISMS (ML-28) 
COMMONLY USED STAT TESTS: EXAMINATION 
OF SPECIMENS BY DARKFIELD MICROSCOPY 
(ML-30) 
COMMONLY USED STAT TESTS: RPR CARD 
TEST (ML-33) 
ML-C VENIPUNCTURE (ML-36) 
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Partner Services Recommendations
 
INTRODUCTION (PS-1) 
·	 Programs should establish the mix of partner ser­
vices that is appropriate to local epidemiology. 
·	 Programs should prioritize patients for partner ser­
vices in terms of specific diseases, local area data, 
the potential for productive intervention, case load, 
and available resources. 
·	 Programs must ensure that DIS and managers pos­
sess the tools, training, and resources necessary to 
conduct program business successfully. 
·	 Programs must have some form of case manage­
ment process in place. Case management “tools” 
should reflect established information needs, should 
be easy to complete, and should provide informa­
tion that can be used to define at-risk populations 
and to target them for intervention. 
·	 Programs should provide interview space that is 
quiet and confidential, and contains at least a desk 
or table, three chairs, a telephone, and educational 
materials needed by the DIS. 
·	 Programs must have written safety guidelines and 
procedures in place and follow these policies. 
·	 Programs must ensure that DIS are aware of and 
comply with safety guidelines. 
PARTNER SERVICES (PS-5) 
·	 Interviews with patients about partner services 
should be planned, client-centered, culturally ap­
propriate, and voluntary. 
·	 Anyone reasonably believed to have been exposed 
to a STD should be treated prophylatically at the 
time of exam based on CDC treatment guidelines. 
·	 Documentation of partner services must be system­
atic, confidential, and regularly reviewed by the next 
level of supervision. 
·	 Partner services should be delivered in one of three 
ways: provider referral, patient referral, or contract 
referral. 
·	 Partner services should be one of a number of pub­
lic health strategies, including accessible clinics, out­
reach, and targeted screening of at risk populations. 
·	 Programs should have the capacity to deliver ser­
vices such as counseling, testing, and treatment, as 
well as referral for other services (e.g., family plan­
ning, drug treatment, social support, and housing). 
SPECIAL CONSIDERATIONS (PS-20) 
·	 Programs should implement a protocol for collabo­
ration with non-health department care providers 
within their own area and with STD programs in 
other jurisdictions. 
·	 Programs should implement a protocol for identi­
fying and developing a case management plan for 
patients with repeat infections. 
EVALUATION AND QUALITY 
ASSURANCE (PS-20) 
·	 Supervisors should regularly observe and document 
individual DIS in the performance of their 
day-to-day activities and should be willing and able 
to demonstrate appropriate skills and behaviors. 
·	 Supervisors should conduct sessions that facilitate 
DIS discussion of case management efforts and pro­
vide opportunity for input from others. 
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·	 Programs should routinely monitor partner services 
to improve efficiency, effectiveness, and quality of 
services. 
·	 Trends in disease found through evaluating part­
ners should be used to monitor disease transmis­
sion and to increase program awareness regarding 
potential outbreaks. 
·	 At a minimum, programs should analyze partners 
who are positive by residence (zip code, address). 
If resources permit, programs should also analyze 
location, demographics, and risk behaviors of part­
ners and should compare positive (including previ­
ously treated partners) with negative partners to see 
what, if any, factors predict positive partners. 
·	 Programs must have a means of regularly evaluat­
ing the effectiveness of partner services by time pe­
riod and disease. 
·	 Programs should develop the capacity to evaluate 
the effectiveness of the partner services by other lo­
cally set criteria to improve services and target them 
better. 
COMMUNITY-BASED OUTREACH 
(PS-23) 
·	 Programs should establish strategies for finding at-
risk persons not identified by an infected index case 
or partner. 
·	 Programs should evaluate or assess the social net­
works that influence disease transmission in their 
area. 
·	 Programs should target screening based upon pro­
gram morbidity data, including information on core 
transmission groups. 
·	 Programs should use information from social net­
work analysis, if available, to assist in targeting both 
field and clinic screening efforts. 
·	 Programs should build partnerships with people 
affected by sexually transmitted diseases to increase 
trust and to facilitate partner services and other in­
terventions. 
·	 Programs should assess which diseases are being 
transmitted within their jurisdiction and how, in­
cluding partner selection patterns and other risk 
factors for infection. 
PARTNER SERVICES APPENDICES 
PS-A INTERVIEW PERIODS BY DISEASE (PS-29) 
PS-B ORIGINAL INTERVIEW FORMAT (PS-30) 
PS-C REINTERVIEW FORMAT (PS-32) 
PS-D CLUSTER INTERVIEW FORMAT (PS-33) 
PS-E LOT SYSTEM FORMS (PS-35) 
PS-F FIELD INVESTIGATIONS (PS-46) 
PS-G INTERSTATE TRANSMISSION OF STD 
INTERVENTION INFORMATION (PS-49) 
PS-H SKILLS INVENTORY (PS-53) 
PS-I EVALUATION TABLES (PS-62) 
PS-J GLOSSARY OF TERMS ASSOCIATED WITH 
PARTNER SERVICES (PS-63) 
PS-K TOOLS FOR NETWORK ANALYSIS (PS-66) 
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Community and Individual Behavior 
Change Interventions 
Recommendations 
INTRODUCTION (BC-1) 
·	 STD prevention programs should develop and main­
tain the capacity to implement community and in­
dividual behavior change interventions. 
·	 STD prevention programs should develop and uti­
lize a behavioral data system to help determine the 
choice of intervention to be implemented and to 
evaluate intervention effectiveness after implemen­
tation. 
·	 STD prevention programs should partner with lo­
cal behavioral intervention experts or STD preven­
tion training centers. 
IDENTIFICATION OF BEHAVIORS & 
CONTEXTS THAT PLACE INDIVIDUALS 
AND COMMUNITIES AT RISK (BC-2) 
·	 STD prevention programs should consider using 
RECAP in the STD program to help determine pre­
vention strategies. 
PREVENTION INTERVENTION 
PLANNING (BC-5) 
·	 Program managers should develop an appropriate 
plan for health communications interventions. 
·	 STD prevention programs should develop behav­
ioral and social surveillance systems appropriate for 
their communities. 
·	 STD prevention programs should develop an ap­
propriate plan for designing, implementing, and 
evaluating behavioral interventions based on local 
surveillance, demographic, and behavioral data 
within the community. 
·	 Program managers must evaluate the outcome of 
behavioral interventions. 
·	 Outcome measures should be linked with behav­
ioral surveillance activities. 
TYPES OF INTERVENTIONS (BC-10) 
·	 Program managers should develop interventions 
based on a sound theoretical knowledge and should 
utilize interventions shown to be effective. 
·	 Programs should collaborate with existing interven­
tion programs such as TB and HIV, and with be­
havioral scientists as needed. 
·	 Programs should have trained, quality staff and 
quality assurance procedures in place when imple­
menting interventions. 
·	 Programs should have an evaluation plan and re­
sults should be compared to established findings. 
Interventions developed at the local level should 
have a strong evaluation plan. 
COMMUNITY AND INDIVIDUAL 
BEHAVIOR CHANGE INTERVENTIONS 
APPENDICES 
BC-A EXAMPLE OF PLANNING MODEL (BC-17) 
BC-B BEHAVIOR CHANGE MODELS (BC-18) 
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Outbreak Response Plan
 
Recommendations (OR-5)
 
·	 STD prevention programs must develop an outbreak 
response plan for specific STDs. 
·	 Outbreak response plans should include: 
·	 standards for surveillance and data management 
·	 procedures for analysis of data, especially in sub­
groups to identify outbreaks in special populations 
and small geographic areas 
·	 a timetable and schedule for review of disease and 
epidemiologic trends 
·	 the threshold at which the plan is to be executed 
·	 involvement of the affected community 
·	 staffing and resource considerations 
·	 notification to state and CDC 
·	 evaluation of the response 
·	 STD prevention programs should implement their 
outbreak response plans upon reaching the thresh­
old that has been set. 
·	 STD prevention programs should evaluate the ef­
fectiveness of the outbreak response plan immedi­
ately after the outbreak has been controlled. 
·	 STD prevention programs should periodically re­
view the outbreak response plan to ensure that nec­
essary staff and other resources are ready to respond 
to an outbreak. 
·	 STD prevention programs should annually review 
and evaluate the attributes of their surveillance sys­
tems to maximize the ability to detect an outbreak. 
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Areas of Special Emphasis 
Recommendations 
CORRECTIONS (SE-1) 
·	 Programs should assess the need for STD services 
in adult and juvenile correctional facilities. 
·	 At a minimum, all programs should implement the 
following low intensity correctional activities (also 
listed in Appendix SE-2). 
·	 Visit the facility to assess the need for STD services 
·	 Meet regularly with corrections representatives 
·	 Distribute STD Treatment Guidelines and other rel­
evant guidelines to adult and juvenile facilities 
·	 Provide referrals to the STD clinic for inmates be­
ing released 
·	 Refine the surveillance system to capture jail-based 
morbidity 
·	 Programs should consider developing special 
projects coordinator positions or specialized cor­
rections positions. 
ADOLESCENTS (SE-3) 
·	 Programs should consider identifying a person to 
serve as “youth liaison” to prevention partners and 
to help develop and improve youth services. 
·	 Programs should facilitate effective partnerships 
with agencies and organizations involved with 
youth. 
·	 Programs should focus adolescent screening efforts 
on those at highest risk, e.g., youth in detention. 
·	 Programs should train staff to counsel and educate 
adolescents. 
·	 Programs should assess barriers for adolescents in 
seeking and accessing care. 
MANAGED CARE (SE-3) 
·	 STD prevention programs need to collaborate with 
state and national-level MCO groups to promote 
STD prevention and control (e.g., best practices 
guidelines in MCOs; develop local and other sur­
veillance data on STDs; feasibility projects examin­
ing innovative strategies for capturing and report­
ing performance data, including the HEDIS 
chlamydia screening measure; outreach methods to 
attract populations at high-risk for STD screening; 
provide the range of partner services through part­
ner elicitation through partner notification and 
management). 
STD/HIV INTERACTION (SE-5) 
·	 Programs should link STD diagnostic and treatment 
services with HIV counseling, testing, and treatment 
services. 
SYPHILIS ELIMINATION (SE-6) 
·	 STD prevention programs should identify a person 
to coordinate syphilis elimination activities. 
·	 STD prevention programs should implement the 
national syphilis elimination plan. 
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OTHER HIGH-RISK POPULATIONS 
(SE-7) 
·	 STD prevention programs should identify popula­
tions that include persons engaging in high-risk be­
haviors or persons with barriers to care and develop 
appropriate interventions. 
AREAS OF SPECIAL EMPHASIS 
APPENDICES 
SE-1 DSTD PROJECT AREA CORRECTIONAL 
HEALTH CARE ASSESSMENT (SE-9) 
SE-2 RANGE OF CORRECTIONAL ACTIVITIES 
(SE-17) 
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